Company Data
Rallybio Corporation
Ticker
RLYB
Current Price
$16.23 -3.79%
Market Cap
$86.0M
Price Target
Refer to Report
Volume
183.9K
52wk Range
$2.16 - $17.5738
Overview
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.